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Abstract
Muscle satellite cells (SCs) are stem cells that reside in skeletal muscles and contribute to regeneration upon muscle injury.
SCs arise from skeletal muscle progenitors expressing transcription factors Pax3 and/or Pax7 during embryogenesis in mice.
However, it is unclear whether these fetal progenitors possess regenerative ability when transplanted in adult muscle. Here
we address this question by investigating whether fetal skeletal muscle progenitors (FMPs) isolated from Pax3GFP/+ embryos
have the capacity to regenerate muscle after engraftment into Dystrophin-deficient mice, a model of Duchenne muscular
dystrophy. The capacity of FMPs to engraft and enter the myogenic program in regenerating muscle was compared with
that of SCs derived from adult Pax3GFP/+ mice. Transplanted FMPs contributed to the reconstitution of damaged myofibers
in Dystrophin-deficient mice. However, despite FMPs and SCs having similar myogenic ability in culture, the regenerative
ability of FMPs was less than that of SCs in vivo. FMPs that had activated MyoD engrafted more efficiently to regenerate
myofibers than MyoD-negative FMPs. Transcriptome and surface marker analyses of these cells suggest the importance of
myogenic priming for the efficient myogenic engraftment. Our findings suggest the regenerative capability of FMPs in the
context of muscle repair and cell therapy for degenerative muscle disease.
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Introduction
The muscular dystrophies are a group of inherited skeletal
muscle disorders that are characterized clinically as progressive
skeletal muscle weakness and wasting [1]. The most common and
severe form of muscular dystrophy is Duchenne muscular
dystrophy (DMD) [2], caused by the mutation or deletion of the
Dmd gene that encodes the structural protein dystrophin [2,3].
Although several new approaches are being developed to retard
the progression of symptoms of DMD, there is as yet no cure [4,5].
Cell transplantation therapy is considered a promising approach to
replace the abnormal skeletal muscle tissue of individuals with
DMD with donor cells that express the missing dystrophin protein
[5,6].
In particular, the therapeutic myogenic potential of satellite cells
(SCs) is noteworthy. Skeletal muscle SCs are mononuclear cells
that reside in their niche, underneath the basal lamina of
multinucleated myofibers [7]. They are mitotically quiescent cells
that begin to proliferate upon myofiber injury or during exercise to
expand a population of skeletal muscle progenitors required to
reconstruct new myofibers [8–11]. SCs without a Dmd mutation
engraft into the muscle of DMD model mice and contribute to the
regeneration of dystrophin positive myofibres [12–14]. Although
these studies suggest the regenerative ability of SCs for DMD, the
mechanisms that control the regenerative ability of SCs when
engrafted into muscle tissues have not been defined.
During embryonic skeletal muscle development, cells expressing
both the paired/homeodomain genes Pax3 and Pax7 in the
dermomyotome delaminate into the myotome and begin to
express myogenic regulatory factors such as MyoD or Myogenin,
leading to the formation of skeletal muscle [15–16]. Pax3 positive
cells in the hypaxial somite migrate into developing limbs and
begin to express the myogenic regulatory factors to found the
skeletal muscle masses of the limb [15,17,18]. Undifferentiated,
mononucleated progenitors expressing Pax3 or Pax7 are first
found located between the basal lamina and plasma membrane of
skeletal muscle fibers at fetal stage [19–20]. Pax7, and Pax3 in a
subset of muscles, marks quiescent SCs in adult muscle [21]. In
spite of detailed knowledge about the origin of SCs during
development, the regenerative myogenic ability of these skeletal
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muscle progenitors for the rescue of DMD skeletal muscle fibers
has not been explored.
In this study, we show that Pax3 positive cells isolated from
wild-type fetal muscle, named fetal skeletal muscle progenitors
(FMPs), have the capacity to regenerate dystrophin positive
myofibres after engraftment into regenerating muscle of DMD-
model mice. However, FMPs have a diminished capacity to
regenerate muscle in vivo, compared to SCs, despite having an
equal capacity to enter the myogenic program in vitro. To define
the molecular mechanisms required for the acquisition of
regenerative capacity by FMPs, we further evaluated the effect
of MyoD expression in FMPs by genetic approaches. We find that
MyoD expression enhances the regenerative capacity of FMPs cell-
autonomously. These results, together with transcriptions and cell
surface marker analyses, suggest the involvement of primed




All animal experiments were carried out according to the
Regulations of Animal Experimentation at Kyoto University. The
protocol was approved by the Animal Research Committee of
Kyoto University (Permit Number: J-6). All injections were
performed under anesthesia, and all efforts were made to minimize
suffering. Mice were humanely sacrificed prior to tissue collection.
Mice
The following mouse lines were used to obtain myogenic cells:
Pax3GFP/+ [20], Rosa26CAG2LSL2tdTomato/+ (Jackson Laboratory, Bar
Harbor, ME; stock number 007914, R26RRFP). The BAC MyoD-
Cre-IRES-nlacZ transgenic line (MyoD-Cre) is described in Fig. S1. A
BAC containing MyoD genomic DNA (2100 kb/+100 kb: clone
RP23-46A24 purchased from BACPAC resource center, CHORI)
was used for targeting with a Cre-IRES-nlacZ reporter into the
ATG site of MyoD. All BAC recombineering was performed with
SW105 Escherichia coli strains [22]. The DMD-null line [23], which
completely lacks dystrophin without any sporadic revertant
dystrophin-positive fibers, was used as host mice. To avoid
immune rejection of donor cells allowing long-term engraftment,
the KSN/Slc line (Foxn12/2, or nude, purchased from Japan SLC,
Hamamatsu, Japan) were crossed with the DMD-null line to obtain
DMD-null;nude compound mice.
Preparation of Cells for Flow Cytometry Analysis and Cell
Sorting
Fetal skeletal muscle progenitors (FMPs) were obtained from
the limbs and diaphragm of E16.5 fetuses of Pax3GFP/+ or
Pax3GFP/+;MyoD-Cre;R26RRFP compound mice. To isolate FMPs
from the limbs, the skin was carefully removed to avoid
contamination with (Pax3)GFP-positive (+) cells present in the
skin [24]. Tissues were dissociated with 0.08% collagenase
(Sigma, St Louis, MO) and 0.08% trypsin (Roche, Basel,
Switzerland) in DMEM/F12 supplemented with GlutaMAX
(Gibco, Carlsbad, CA) at 37uC for 40 minutes. Dissociated cells
were resuspended with 1% fetal bovine serum (FBS; Gibco) in
DMEM-high glucose (Gibco) and filtered with 35-mm cell
strainers (BD, Franklin Lakes, NJ). Satellite cells (SCs) were
prepared from abdominal muscles and diaphragms of 8–
12 week old Pax3GFP/+ mice by enzymatic dissociation as
previously described [14]. For live cell sorting, single-cells were
Figure 1. FMPs are more heterogeneous than SCs. (A) Immunohistochemistry of a FMP on longitudinal sections of limbs at E16.5 for GFP
(green), Laminin (white). Nuclei were stained with DAPI. An arrow indicates a GFP-positive FMP. Scale bar = 10 mm. (B) Adult myofibers (nuclei were
stained with DAPI) isolated from the diaphragms of the Pax3GFP/+ line. An arrow indicates a GFP-positive SC. Scale bar = 25 mm. (C,D) Representative
fluorescence-activated cell sorting profiles for (Pax3)GFP+ cells from fetuses (C) and adult muscle (D). (E,F) Forward scatter and side scatter profiles of
(Pax3)GFP cells gated in (C) and (D). FMPs, fetal skeletal muscle progenitors; SCs, satellite cells.
doi:10.1371/journal.pone.0063016.g001
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stained with 1 mg/ml propidium iodide (PI) to exclude PI+ dead
cells. Cell sorting was performed with FACSAria II Cell Sorter
(BD). The complete (Pax3)GFP+ fraction was taken for analysis
using FlowJo (Tree Star, Ashland, OR).
Characterization of FMPs and SCs in vitro
Isolated FMPs and (Pax3)GFP+ SCs were resuspended in the
growth medium DMEM/F12 (Gibco) containing 20% FBS
(Gibco) and 2% Ultroser G (Pall, Port Washington, NY). Cells
were cultured in 35-mm dishes coated with 2% gelatin at 56103
cells per dish. Four days later, the medium was changed to the
differentiation medium, which consisted of DMEM/F12 with 2%
horse serum (Sigma).
For immunocytochemical analysis, cultured cells were fixed
with 4% paraformaldehyde (PFA) and permeabilized with 0.2%
Triton X100, 50 mM NH4Cl in PBS. Cells were incubated with
5% Blocking One (nacalai tesque, Kyoto, Japan). The following
antibodies were used as primary antibodies: anti-MyoD (1:100,
Santa Cruz Biotechnology, Santa Cruz, CA), anti-Myogenin
(1:100, DAKO, Glostrup, Denmark), anti-Troponin T (1:250,
Sigma). Secondary antibodies were coupled to flurochromes Alexa
568 or 647 (1:300, Molecular Probes, Carlsbad, CA). 4,6-
Diamidino-2-phenylindole (DAPI, 1:10,000, Molecular Probes)
was used to counter-stain nuclei. For quantification, at least 500
cells in culture were counted from randomly chosen fields for each
stage.
Engraftment of Isolated FMPs and SCs into Injured
Muscle Tissues
DMD-null or DMD-null;nude host mice were injected with 50 ml
of 10 mM cardiotoxin (Sigma) the day before transplantation. For
engraftments, purified FMPs and SCs (26104 cells per 20 ml of
PBS) were injected into tibialis anterior (TA) muscles of
anesthetized host mice. Control TA muscles were injected with
medium as a negative control.
TA muscles were removed two weeks after transplantation.
Injected muscles were frozen in liquid nitrogen-chilled isopentane.
For immunofluorescence staining, serial 10 mm cryosections were
collected and blocked with 5% Blocking One in PBS. Antibody for
dystrophin (1:500, Abcam, Cambridge, UK) was diluted in 5%
Blocking One in PBS. Alexa fluor 568 goat-anti-rabbit IgG was
used as a secondary antibody. DAPI (1:10,000, Molecular Probes)
was used to counter-stain nuclei. Stained tissues were photo-
graphed with a Zeiss Axio Imager Z1 (Carl Zeiss, Oberkochen,
Germany). For quantification of dystrophin positive fibers, serial
transverse sections were cut throughout the entire TA muscle.
Each TA muscle generated 20–25 slides, each slide consisting of
20–25 serial sections. Five different slides were stained for
dystrophin. The one section in the slide with the maximum
number of dystrophin positive myofibers for each animal was
counted. Graphs display the mean 6 s.e.m. for each engrafted
animal.
Immunohistochemistry and Quantification of Engrafted
FMPs and SCs
To maintain GFP fluorescence in the tissue, TA muscles were
fixed in 1% paraformaldehyde, 0.1% Triton X-100 in PBS at
4uC for 2 hours and incubated in 15% sucrose in PBS at 4uC
overnight. The TA muscles were embedded in Frozen Section
Compound (Leica Microsystems, Wetzlar, Germany) and were
frozen in liquid nitrogen. For immunofluorescence staining,
serial 10 mm cryosections were collected and treated with 10%
goat serum in PBS. Antibodies for GFP (1:200, Molecular
Probes), dystrophin (1:500, Abcam), and laminin (1:500, Enzo
Life Sciences, Farmingdale, NY) were diluted in 0.5% Triton
X-100 in PBS and were incubated overnight at 4uC. Alexa fluor
488 goat-anti-chick, 568 goat-anti-rabbit, and 647 goat-anti-rat
(1:500, Molecular Probes) IgGs were used as secondary
antibodies. Stained tissues were photographed with a Leica
TCS-SP5 Confocal Microscopy (Leica Microsystems). For
quantification of (Pax3)GFP+ cells underneath laminin and
outside the muscle fiber, the entire TA muscle was sectioned.
Each TA muscle generated 20 slides, each slide was about
200 mm away from the previous slide. Each slide consisted of
nine serial sections, and four different slides were stained for
GFP, dystrophin, and laminin. The average number of
Figure 2. FMPs and SCs show similar myogenic differentiation potential in vitro. (A,B) Immunocytochemistry of FMPs and SCs for MyoD
(A) and Myogenin (B) during culture (days 3 and 5). DAPI was used for to stain nuclei. Scale bar = 50 mm. (C,D) Quantitative analysis of MyoD (C) and
Myogenin (D) in cultured FMPs and SCs. Data are reported as mean and s.d. of 500–1000 cells per staining from three independent experiments. P-
values indicated on figures are ,0.01 (**). (E,F) Phase contrast micrographs of FMPs (E) and SCs (F) after 7 days in culture. (G,H)
Immunocytochemistry of FMPs (G) and SCs (H) shown in (E,F) for Troponin T and DAPI. Scale bar = 50 mm. FMPs, fetal skeletal muscle progenitors;
SCs, satellite cells.
doi:10.1371/journal.pone.0063016.g002
Figure 3. Engrafted FMPs restore dystrophin expression in
DMD-nullmice. (A–C) Immunostaining for dystrophin in TA muscles of
DMD-null mice injected with medium (A), FMPs (B), and SCs (C) 2 weeks
after intramuscular engraftment. Scale bar = 100 mm. (D) Quantification
of dystrophin+ fibers in TA engrafted with FMPs (n= 7 recipient mice)
and SCs (n=7 recipient mice). Data is reported as the mean and s.e.m.
from all engrafted mice. P-value indicated on the figure is ,0.05 (*).
(E,F) Immunostaining for dystrophin in TA muscles of DMD-null;nude
mice injected with medium (E) and FMPs (F), 24 weeks after
engraftment. Scale bar = 100 mm. FMPs, fetal skeletal muscle progen-
itors; SCs, satellite cells; TA, tibialis anterior.
doi:10.1371/journal.pone.0063016.g003
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Figure 4. Recovery of (Pax3)GFP+ cells from FMP- and SC-engrafted TA muscles. (A,B) A representative fluorescence-activated cell sorting
profile for (Pax3)GFP+ cells from control (A) and FMP-engrafted (B) TA muscle. The percentage of cells that express GFP is indicated. (C–F)
Immunocytochemistry for Pax7 (D) and GFP (E) of freshly isolated (Pax3)GFP+ cells from FMP-engrafted TA muscles. Scale bars = 5 mm. (G,H) Phase
contrast micrographs (G) and immunocytochemistry with anti-Troponin T antibodies (H) of isolated (Pax3)GFP+ cells cultured in proliferation and
differentiation conditions for 6 days. Scale bar = 50 mm. (I–P) Immunostaining for laminin, dystrophin, and GFP in TA muscles of DMD-null mice
injected with FMPs (I–L) and SCs (M–P) 2 weeks after intramuscular engraftment. Arrows indicate (Pax3)GFP+ cells underneath laminin and outside of
dystrophin. Scale bar = 10 mm. (Q) Quantification of (Pax3)GFP+ cells underneath laminin and outside of dystrophin in TA engrafted with FMPs (n=5
recipient mice) and SCs (n=5 recipient mice). Data is reported as the mean and s.e.m. from all engrafted mice. P-value indicated on the figure is
,0.05 (*). FMPs, fetal skeletal muscle progenitors; SCs, satellite cells; TA, tibialis anterior.
doi:10.1371/journal.pone.0063016.g004
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(Pax3)GFP+ cells were counted in nine sections obtained from
four different slides of TA from n=5 mice.
Immunohistochemistry of Fetal Limbs Sections
Limbs from fetuses collected at E16.5 days post coitus were
fixed with 4% PFA at room temperature for 2 hours followed by
overnight immersion in 20% sucrose in PBS at 4uC. Fixed tissue
was embedded in Optimal Cutting Temperature (O.C.T.)
Compound (Sakura Finetek Japan, Tokyo, Japan) for cryosections.
Immunohistochemistry was carried out using the following
antibodies: anti-GFP (1:500, Millipore, Billerica, MA) and anti-
MyoD (1:200, Santa Cruz Biotechnology). Alexa fluor 488 goat-
anti-rabbit, goat-anti-chick, 568 goat-anti-rabbit, and 647 goat-
anti-rat (1:500, Molecular Probes) IgGs were used as secondary
antibodies. Stained tissues were photographed with a Leica TCS-
SP5 Confocal Microscopy (Leica Microsystems). For quantitative
analyses of immunostained tissue, at least 100 (Pax3)GFP+ cells
from randomly chosen fields in the limbs were counted from three
fetuses.
Immunocytochemistry of Freshly Isolated FMPs and SCs
FMPs and (Pax3)GFP+ SCs were collected by cell sorting and
plated on gelatin-coated dishes for 30 minutes to allow attach-
ment. For immunocytochemistry, cells were fixed with 4% PFA
and processed for immunostaining as above. For quantitative
analyses of immunostained cells, at least 100 (Pax3)GFP+ cells in
culture from randomly chosen fields were counted from three
independent experiments.
Transplantation of Sorted MyoD-positive and -negative
FMPs
To maintain RFP fluorescence in the tissue, transplanted TA
muscles were fixed with 2% PFA at 4uC for 1 hours followed by
washing with PBS at room temperature for 30 minutes. Fixed TA
was frozen and processed for immunostaining with anti-dystrophin
antibody as mentioned above. Quantitative analyses of dystrophin
positive fibers were carried out as mentioned above.
Profiles of Cell Surface Markers in FMPs and SCs
Cells were washed in 500 ml of Hanks’ Balanced Salt Solutions
(HBSS) with 1% bovine serum albumin (BSA). We used the
following primary antibodies on 106 cells in 100 ml of HBSS 1%
BSA: biotinylated anti-CD34 (1:100, clone RAM34, eBioscience,
San Diego, USA), phycoerythrin (PE)-conjugated anti-CD184
(1:40, clone 2B11/CXCR4, eBioscience), PE-conjugated anti-c-
Met (1:80, clone eBioclone 7, eBioscience), PE-conjugated anti-
Sca-1 (1:400, clone D7, eBioscience). For secondary staining,
streptavidin coupled to APC, APC-conjugated goat anti-mouse
IgG were used respectively. Flow cytometry analysis was
preformed with a FACSAria II Cell Sorter.
Quantitative Real-time Reverse Transcription Polymerase
Chain Reaction Analysis
Total RNA was prepared using the RNeasy Plus Micro kit
(Qiagen, Hilden, Germany) from freshly isolated cells. Synthesized
cDNA was prepared from total RNA samples using SuperScript
III kit (Invitrogen) with random hexamers for quantitative real-
time reverse transcription polymerase chain reaction (qRT-PCR).
All qRT-PCR reactions were carried out in triplicate using Power
SYBR Green PCR Master Mix (Applied Biosystems, Carlsbad,
USA) and StepOne Real Time PCR System (Applied Biosystems).
All qRT-PCR results were normalized to the expression level of
ribosomal protein L13A (Rpl13A) as a control gene. Primer
sequences (59 to 39) are listed in the Table S1.
Statistics
Statistical analysis was performed with R software using Welch
Two Sample t-test, 2-sample test for equality of proportions, and
Bonferroni test.
Results
FMPs are more Heterogeneous than SCs
To obtain fetal skeletal muscle progenitors (FMPs), (Pax3)GFP-
positive (+) cells were isolated by fluorescence activated cell sorting
(FACS) from limbs and diaphragm of E16.5 fetuses from Pax3GFP/
+ mice (Fig. 1A). Satellite cells (SCs) expressing Pax3 were
prepared from abdominal muscle and diaphragm of adult
Pax3GFP/+ mice as previously reported (Fig. 1B) [14]. (Pax3)GFP+
cells represented 1–6% of the total mononuclear cells isolated from
the tissue of fetal limbs and adult skeletal muscle fibers (Fig. 1C,D).
Isolated SCs were homogenous, with low-variation in forward
scatter (FSC) and side scatter (SSC) gating, indicating small and
Figure 5. FMPs express MyoD in developing limbs. (A–F)
Immunohistochemistry of FMP cells on longitudinal sections of limbs
at E16.5 for GFP (A,D), MyoD (B,E) and merged with DAPI (C,F). MyoD-
positive (A–C) and -negative (D–F) FMPs are shown. Scale bar = 10 mm.
(G) Percentage of MyoD-positive and MyoD-negative cells in
(Pax3)GFP+ cells in limbs at E16.5 with data reported as the mean
and s.d. of three fetuses. (H–M) Immunocytochemistry of freshly
isolated FMPs (H–J) and SCs (K–M) for GFP (H,K), MyoD (I,L), and merged
with DAPI (J,M). Arrows in H–J indicate MyoD-positive FMPs. Scale
bar = 20 mm. (N) Percentage of MyoD-positive and MyoD-negative cells
of freshly isolated FMPs and SCs (n= 100 cells par condition). FMPs, fetal
skeletal muscle progenitors; SCs, satellite cells.
doi:10.1371/journal.pone.0063016.g005
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non-granular cells, as previously reported (Fig. 1F) [14]. In
addition, SCs homogenously expressed GFP at high levels
(Fig. 1D). In contrast, FMPs were heterogeneous with respect to
the intensity of GFP expression (Fig. 1C), as well as FSC and SSC
profiles (Fig. 1E). Taken together these findings indicate that FMPs
are more heterogeneous than SCs.
FMPs have Similar Myogenic Potential to SCs in vitro
We next assessed the myogenic differentiation potential of FMPs
in vitro and compared them with those of SCs. Sorted FMPs and
SCs were plated on gelatin-coated dishes and stained with MyoD
and Myogenin after 1 to 6 days in culture (Fig. 2A–D). FMPs and
SCs had a similar temporal expression pattern of MyoD in culture
(Fig. 2A,C). In terms of Myogenin expression, 5–15% of SCs were
positive for Myogenin on day 2 and 3, respectively compared with
27–35% of FMPs (Fig. 2B,D). After 4–6 days in culture, however,
Myogenin expression in FMPs was comparable to that of SCs
(Fig. 2B,D). After 7 days in culture, FMPs and SCs generated
multinucleated myotubes (Fig. 2E,F) expressing Troponin T
(Fig. 2G,H). Therefore, FMPs and SCs were highly myogenic in
terms of MyoD expression and differentiation into myotubes while
part of the FMP population differentiated more rapidly than SCs.
FMPs Engraft DMD-null Skeletal Muscles in vivo
To compare regenerative capacities, FMPs and SCs (26104
cells) were injected into cardiotoxin-injured tibialis anterior (TA)
muscles of dystrophin knock-out mice (DMD-null mice) [23]. The
expression of dystrophin in host muscle fibers was evaluated two
weeks after engraftment. Immunostaining showed the presence of
dystrophin-positive (+) fibers in host muscle sections from DMD-
Figure 6. MyoD-positive FMPs have more regenerative ability than MyoD-negative FMPs. (A) Representative fluorescence-activated cell
sorting profiles for (MyoD)RFP- and (MyoD)RFP+ cells from Pax3GFP/+;MyoD-Cre;R26RRFP fetus. (B,C) A fluorescence stereomicroscope view of RFP
fluorescence in TA muscles of DMD-null mice transplanted with (MyoD)RFP- (B) and (MyoD)RFP+ FMPs (C). Scale bar = 2.5 mm. (D–I)
Immunohistochemistry for RFP (D,E), dystrophin (E,F), and merged with DAPI (F,I) in (MyoD)RFP- (D–F) and (MyoD)RFP+ (G–I) FMP engrafted TA
muscles. Scale bar = 20 mm. (J) Quantification of dystrophin+ fibers in TA muscles engrafted with (MyoD)RFP- and (MyoD)RFP+ FMPs. Error bars
represent the mean and s.e.m. from 3 engrafted mice. P-value indicated on the figure is ,0.01 (**). FMPs, fetal skeletal muscle progenitors; TA, tibialis
anterior.
doi:10.1371/journal.pone.0063016.g006
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Figure 7. SCs are more primed into the myogenic program than FMPs. (A) CD34 expression of (MyoD)RFP- FMPs, (MyoD)RFP+ FMPs, and
SCs. Flow cytometry histograms show a control staining profile (gray line) and CD34 (red line). The percentage of cells expressing CD34 is indicated.
(B) Relative amounts of the indicated transcripts determined by quantitative reverse transcription polymerase chain reaction among (MyoD)RFP-
FMPs, (MyoD)RFP+ FMPs, and SCs. Data is normalized to the expression of transcripts for Rpl13A. Data is reported as the mean and s.e.m. (n=3). P-
values indicated on figures are no significant difference (NS), ,0.01 (**), and ,0.001 (***). FMPs, fetal skeletal muscle progenitors; SCs, satellite cells.
doi:10.1371/journal.pone.0063016.g007
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null mice engrafted with SCs and FMPs (Fig. 3B,C). No
dystrophin+ fibers were present in non-grafted TA muscles
(Fig. 3A). Serial cryosections of the TA after FMP transplantation
showed continuous dystrophin expression (Fig. S2). Quantification
of dystrophin+ fibers in transplanted DMD-null mice showed that
SCs had higher efficiency of engraftment than FMPs (79.8617.5
fibers with SCs, n=7 independent experiments, and 1966.9 fibers
with FMPs, n=7 independent experiments, Fig. 3D). To
determine whether the engraftment of FMPs was sustained, we
investigated the restoration of dystrophin expression in skeletal
muscle fibers of host mice at 24 weeks after transplantation into
DMD-null;nude mice [25]. Dystrophin+ fibers were also detected in
muscles of DMD-null;nude mice (n=3 independent experiments) 6
months after transplantation (Fig. 3F), whereas the control mice
presented no dystrophin+myofibers (Fig. 3E). No tumor formation
was observed in mice up to 6 months after the engraftment (data
not shown). These observations suggest that FMPs were able to
contribute to regenerated fibers over a long period but that
engraftment of skeletal muscles was less efficient than SCs.
Transplanted FMPs Contribute to the SC Compartment
(Pax3)GFP+ SCs isolated from the diaphragm retain their
(Pax3)GFP+ identity in the environment of engrafted TA muscle,
where endogenous SCs rarely express Pax3 [14]. To examine
whether FMPs could also retain their (Pax3)GFP-expression in the
engrafted muscle, the host TA muscles were analyzed by flow
cytometry two weeks after engraftment. Although no (Pax3)GFP+
cell was detected in control TA muscles (Fig. 4A), (Pax3)GFP+
donor cells could be detected from the engrafted TA muscles
(Fig. 4B). Freshly sorted donor-derived (Pax3)GFP+ cells were
positive for Pax7 (Fig. 4C–F). In addition, these cells also expressed
TroponinT after 6 days in culture (Fig. 4H).
To compare the properties of FMPs and SCs to occupy the
satellite cell-niche of the engrafted muscle, we performed
immunostaining of (Pax3)GFP, laminin, and dystrophin in FMP-
or SC-transplanted TA muscles of DMD-null mice two weeks after
transplantation. Engrafted (Pax3)GFP+ cells were located under
the basement membrane (inside laminin) and outside of the muscle
fiber (outside of dystrophin), in both FMP- and SC-transplanted
muscles (Fig. 4I–P). A higher number of (Pax3)GFP+ cells
occupying the satellite cell-niche was found in SC-transplanted
TAs than FMP-transplanted ones (2.460.6 GFP+ cells/section
with SCs, n=5 recipient mice, and 0.160.05 GFP+ cells/section
with FMPs, n=5 recipient mice, Fig. 4Q). These results show that
transplanted FMPs contribute to the adult muscle SC compart-
ment though less efficiently than SCs.
We also isolated (Pax3)GFP+ cells from embryonic muscle (Fig.
S3A–C). These cells did not survive in culture (data not show) or
did not show significant levels of engraftment (Fig. S3D,E), in
keeping with a previous report [26]. We therefore conclude that
fetal but not embryonic muscle progenitors have the potential to
repair adult skeletal muscle.
MyoD Protein is Expressed in FMPs, but not in SCs
We next examined for factors that account for the different
engraftment efficiencies between FMPs and SCs. Expansion of
SCs in culture before engraftment results in the activation of
MyoD protein expression and reduced regenerative capacity
[14,27]. Therefore, the lower regenerative ability exhibited by
FMPs, compared to freshly isolated SCs, could be due to higher
expression of MyoD protein. We examined the ratio of MyoD
protein-positive cells in FMPs of the limbs, of fetuses at E16.5 of
Pax3GFP/+ mice. Half (5667%) of (Pax3)GFP+ cells detected in
limb muscles expressed MyoD (Fig. 5A–E,G). Next, we investi-
gated whether these findings in limb muscles were also observed in
the freshly isolated cells from adult and fetal muscles after cell-
sorting. Most freshly isolated SCs expressing (Pax3)GFP were
negative for MyoD (Fig. 5K–L for immunostaining and Fig. 5N
for quantification analysis), in agreement with other reports
[27,28]. In contrast, half of isolated FMPs expressed MyoD
(Fig. 5H–J,N). This reflects the developmental program of skeletal
muscle progenitors entering the limbs, which are marked by
(Pax3)GFP, and about half of these progenitors have already
entered the myogenic program, marked by MyoD expression, and
will contribute to the formation of new muscle fibers [20].
MyoD-positive FMPs have more Regenerative Ability
than MyoD-negative FMPs
We then examined whether MyoD expression in FMPs also
affected their efficiency of engraftment. We isolated FMPs from
Pax3GFP/+;MyoD-Cre;R26RRFP mice, in which all descendants that
had expressed MyoD-Cre at any time point before analyses were
marked by the expression of RFP (Fig. S1). We obtained
(Pax3)GFP+ fractions from fetuses of Pax3GFP/+;MyoD-Cre;R26RRFP
mice at comparable proportions to those from Pax3GFP/+ mice
(Fig. 6A and Fig. S4). Half of the (Pax3)GFP+ cells were positive
for RFP, which was comparable to immunostaining for MyoD of
FMPs in vivo and in vitro (Figs 5, 6A). Most of freshly isolated
(MyoD)RFP+ FMPs were positive for MyoD protein (Fig. S4).
This reflects that most (MyoD)RFP+ cells at fetal stage express
MyoD whereas (MyoD)RFP+ SCs in adult muscles are negative
for MyoD (data not shown and [29]). The (MyoD)RFP+;(-
Pax3)GFP+ FMPs and the (MyoD)RFP-;(Pax3)GFP+ FMPs
(26104 cells) were injected into TA muscles of DMD-null mice,
as described above. Two weeks after engraftment, RFP+myofibers
were observed within the (MyoD)RFP- (Fig. 6B) and (MyoD)RFP+
FMP (Fig. 6C) engrafted TA muscles. Immunostaining showed the
expression of dystrophin in RFP+ myofibers derived from both
explants (Fig. 6D–I). However, the number of dystrophin+ fibers
in TA muscle of the DMD-null mice transplanted with MyoD-
positive FMPs was higher than that of TA muscle engrafted with
MyoD-negative FMPs (5060.5 fibers and 22.661.4 fibers,
respectively, n=3 independent experiments; Fig. 6J). These
findings demonstrate that engrafted MyoD-positive FMPs had a
greater regenerative potential than engrafted MyoD-negative
FMPs.
MyoD-positive FMPs are more Transcriptionally Primed
for Myogenesis
We hypothesized that the myogenic immaturity of FMPs could
affect the efficiency of engraftment, and therefore investigated
surface markers, which are known to be expressed in adult SCs.
Cxcr4, Sca1, and cMet, which are expressed in some isolated SC
populations [30–32], were not present in FMPs or (Pax3)GFP+
SCs (Fig. S5). (MyoD)RFP- and (MyoD)RFP+ FMPs are
heterogeneous for CD34 expression, which is in marked contrast
to its homologous expression in SCs (Fig. 7A).
To evaluate the commitment status of these cells, qRT-PCR
was carried out to compare gene expression. Pax3 transcripts in
SCs were higher than that of (MyoD)RFP- and (MyoD)RFP+
FMPs, indicating that GFP expression reflects endogenous Pax3
expression (Fig. 1C,D and Fig. 7B). Transcripts for Pax7 and Myf5,
which are reported to be makers of SCs [33,34], and Desmin, a
marker for myogenic commitment, were highest in SCs. Tran-
scripts for MyoD was higher in SCs and (MyoD)RFP+ FMPs than
in (MyoD)RFP- FMPs. Transcripts of Myogenin, which is associated
with myogenic differentiation, were also higher in (MyoD)RFP+
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FMPs and SCs. These transcription profiles imply that SCs are
more primed for myogenic commitment than FMPs, and
(MyoD)RFP+ FMPs are more primed for the myogenic program
than (MyoD)RFP- FMPs.
Discussion
This study demonstrates the regenerative potential of FMPs,
Pax3-expressing skeletal muscle progenitors at the fetal stage.
Comparison with (Pax3)GFP+ SCs isolated from adult muscle led
us to conclude that FMPs are effective but less efficient in
constitution of dystrophin-positive fibers and occupation of the
satellite-cell niche in the DMD model mice. Meanwhile, they
undergo similar activation of MyoD and muscle differentiation
when cultured in vitro (Figs 2, 3), indicating that the myogenic
activity of isolated cells in culture is not predictive of their
efficiency for regenerative myogenesis after transplantation.
FMPs and SCs have clear differences in their transcriptome
profiles. This may partly reflect the fact that adult SCs are
quiescent whereas fetal myogenic progenitors are a proliferating
population [15]. SCs have higher levels of transcripts for myogenic
genes such as MyoD and Myf5 as well as Pax3 and Pax7. Pax7 is
required for SC specification while Myf5 is essential for proper
regenerative myogenesis [34–36]. The analyses of cell surface
markers show that 60% of FMPs are positive for CD34 with
variable intensity, whereas all SCs express CD34 [14,27,33].
Together, the inefficient regenerative ability of FMPs is likely
attributed to lower levels of Pax7, Myf5, and CD34 that are
involved in myogenic specification, differentiation, and cell
adhesion of SCs.
It is well established that SCs are a heterogeneous population
[13], especially in terms of Pax3 expression [14,21]. We used fetal
limbs as sources for FMPs, but SCs were collected from abdominal
and diaphragm muscles to obtain enough numbers of (Pax3)GFP+
cells for the transplantation because few SCs of limb muscles
express Pax3 [14,21]. We cannot exclude the possibility that the
different source of cells between adult and fetal muscles could
affect to their transcription profiles and transplantation efficien-
cies. It would be useful to further investigate whether the SCs from
different skeletal muscles might have the different regeneration
potentials.
In this study, we also found that part of FMPs in which the
MyoD gene had been activated engrafted more efficiently than the
rest of FMPs that had not experienced activation of the MyoD
gene. MyoD is required for skeletal muscle regeneration in vivo
[37]. Genetic tracing experiments, using a MyoD Cre with a
conditional reporter gene had indicated that most SCs had
activated MyoD at prenatal stages [29]. Adult SCs indeed continue
to transcribe both Myf5 and MyoD when the total (Pax3)GFP+
population is analyzed (Fig. 7B; [38]), which may reflect
perduration of GFP in few activated cells that have progressed
towards differentiation, although the MyoD protein does not
accumulate in the quiescent cells. The MyoD protein starts to
accumulate when SCs are activated upon regeneration. In the case
of Myf5, the low level of Myf5 protein in quiescent SCs has been
shown to be due to sequestration of the Myf5 mRNA, together
with miR31 which blocks its activity in mRNP particles [39]. A
MicroRNA mediating repression of transcripts required for
proliferation has also been reported in quiescent SCs [40]. These
observations are consistent with the idea that SCs are primed for
rapid proliferation and entry into the myogenic program, which
depends on expression of Myf5 and MyoD proteins. When SCs
were cultured, they also re-express MyoD protein, but engraft less
well than freshly isolated cells [14]. Thus, re-expression of MyoD
protein and progression of the myogenic program could affect
regeneration potential negatively.
In the FMP population, we also observe transcripts of these
myogenic determination genes MyoD and Myf5, although levels
are lower than in SCs. In contrast to freshly isolated quiescent SCs,
MyoD protein is present in 56% of (Pax3)GFP+ FMPs. This may
mainly include population that has entered the myogenic program
and will subsequently form new muscle during the extensive
growth of the fetal period. A recent report suggests that there are
at least two distinct SC populations, one is responsible for the
growth of skeletal muscles and another one is activated by muscle
injury and survives transplantation [41]. It remains to be
elucidated whether FMPs are destined to become one of these
two SC populations.
We used a MyoD-Cre line that we had developed with a
conditional R26RRFP reporter allele to examine what proportion of
FMPs express or had expressed MyoD at E16.5. About 50% of the
(Pax3)GFP+ cells were RFP+, and most of the RFP+ cells were
also MyoD protein-positive. These results indicate that the
myogenic progenitor population at this fetal stage has not yet
acquired post-transcriptional mechanisms that prevent expression
of MyoD protein and that MyoD-negative FMPs do not derive
from progenitors that had previously activated this myogenic
determination gene. Examination of transcripts in the RFP+
fraction from MyoD-Cre;R26RRFP;Pax3GFP/+ of (Pax3)GFP+
showed that the myogenic differentiation gene, Myogenin, as well
as Desmin, an early marker of myogenesis, are also transcribed
higher in this population than in the RFP- cells. The RFP+
fraction of the FMPs engrafts better than the RFP- cells that have
not yet entered the myogenic program. Our findings therefore
underline the importance of myogenic priming in the context of
muscle repair and cell therapy for degenerative muscle disease.
Although the therapeutic potentials of SCs are attractive, their
regenerative ability is greatly reduced after cell culture, rendering
expansion in vitro unsatisfactory [14,27]. Several studies demon-
strated expansion of SCs maintaining engraftment potential
[42,43] but acquisition of enough amounts of SCs for transplan-
tation remains to be a major challenge. Thus other novel cell
sources of large quantities of cells are required. Undifferentiated
cells like embryonic stem (ES) cells or induced pluripotent stem
(iPS) cells are capable of unlimited self-renewal and have the
potential to differentiate into any cell type [44]. Myogenic
progenitors that form skeletal muscle can be induced from ES or
iPS cells in vitro after overexpression of Pax3 or Pax7 [45,46]. It
remains to be elucidated which myogenic populations along the
developmental cascade are obtained in such protocols. This is a
major issue, highlighted by recent evidence that cardiac progen-
itors derived from ES cells give rise to immature cardiomyocytes
[47], with the risk of arythmias after engraftment into the infarcted
heart. Our results show that skeletal muscle progenitors at the fetal
stage have the capacity to repair adult skeletal muscle. In addition
to demonstrating the regenerative ability of these cells in an adult
muscle environment, our findings are of importance to potential
ES and iPS derived cell replacement therapies for skeletal muscle.
Supporting Information
Figure S1 RFP expression pattern inMyoD-Cre;R26RRFP
embryos. (A) Schematic representation of MyoD-Cre dependent
recombination and derivative reporter alleles. (B–D) MyoD-Cre
activated expression of RFP from the tdTomato allele and b-
galactosidase from nlacZ reporter in R26RRFP mice carrying
MyoD-Cre-IRES-nlacZ at E14.5. (E–G) RFP-expressing regions
co-localize with MyoD labeling in the forelimb at E14.5.
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(TIF)
Figure S2 Immunohistochemistry on serial sections of
FMP-engrafted tibialis anterior (TA) muscles, Related to
Figure 3. (A–D) Four serial sections (1500 mm apart between
each section, proximal (A) to distal (D)) of a field containing
dystrophin+ fibers in the TA muscles of DMD-null mice injected
with FMPs. Scale bar = 100 mm. FMPs, fetal skeletal muscle
progenitors.
(TIF)
Figure S3 (Pax3)GFP+ cells from embryonic muscle did
not show engraftment. (A) Pax3GFP/+ fetus at E10.5 viewed
under a fluorescence stereomicroscope. Red dotted lines indicate
the dissected region. (B) Representative fluorescence-activated cell
sorting profiles for (Pax3)GFP+ cells from embryos. (C) Forward
scatter and side scatter profiles of (Pax3)GFP+ cells gated in (B).
(D,E) Immunostaining for dystrophin (D) and merged with DAPI
(E) in tibialis anterior (TA) muscles of DMD-null mice injected with
(Pax3)GFP+ isolated from E10.5 embryos 2 weeks after intramus-
cular engraftment. Scale bars = 100 mm.
(TIF)
Figure S4 (MyoD)RFP+ cells were positive for MyoD
protein, Related to Figure 6. (A) Gating strategy to isolate
(MyoD)RFP- and (MyoD)RFP+ FMPs. GFP and RFP expressing
cells from wild-type, Pax3GFP/+, MyoD-Cre;R26RRFP, and Pax3GFP/
+;MyoD-Cre;R26RRFP mice. (B–I) Immunocytochemistry of isolated
(MyoD)RFP- and (MyoD)RFP+ FMPs for RFP (B,F), GFP (C,G),
MyoD (D,H), and DAPI (E,I). Scale bar = 50 mm. FMPs, fetal
skeletal muscle progenitors.
(TIF)
Figure S5 Surface marker profiles of FMPs and SCs,
Related to Figure 7. FMPs and SCs were negative for Cxcr4,
Sca1, and cMet. FMPs, fetal skeletal muscle progenitors; SCs,
satellite cells.
(TIF)
Table S1 Primers used for the expression analysis of
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